Fast Market Research

Recently Released Market Study: SWITCH Biotech LLC - Product Pipeline Review - 2013

Fast Market Research recommends "SWITCH Biotech LLC - Product Pipeline Review - 2013" from Global Markets Direct, now available

 
Repost This

Boston, MA -- (SBWIRE) -- 02/04/2014 -- Global Market Direct's pharmaceuticals report, "SWITCH Biotech LLC - Product Pipeline Review - 2013" provides data on the SWITCH Biotech LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, SWITCH Biotech LLC's corporate website, SEC filings, investor presentations and featured press releases, both from SWITCH Biotech LLC and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- SWITCH Biotech LLC - Brief SWITCH Biotech LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of SWITCH Biotech LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of SWITCH Biotech LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the SWITCH Biotech LLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate SWITCH Biotech LLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of SWITCH Biotech LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the SWITCH Biotech LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with SWITCH Biotech LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of SWITCH Biotech LLC and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Braasch Biotech LLC - Product Pipeline Review - 2013
- MedImmune, LLC - Product Pipeline Review - 2013
- Bharat Biotech International Limited - Product Pipeline Review - 2013
- Aduro BioTech, Inc. - Product Pipeline Review - 2013
- ReGenX Biosciences, LLC - Product Pipeline Review - 2013
- Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Digna Biotech, S.L. - Product Pipeline Review - 2013
- Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2013
- Nuron Biotech, Inc. - Product Pipeline Review - 2013
- Oncolytics Biotech Inc. - Product Pipeline Review - 2013